Jesus L. Prieto
Pamplona, NC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 133 publications
Radiotherapy and AAV-based immunotherapy: A new alliance for cancer treatment.
Journal: Molecular therapy. Oncology
Published: July 13, 2026
Screening for Mutations Causing ACOX2 Deficiency-associated Hypertransaminasemia in Patients with Cryptogenic Liver Injury.
Journal: Journal of clinical and translational hepatology
Published: July 07, 2025
Application of a split-Cre system for high-capacity adenoviral vector amplification.
Journal: Biotechnology journal
Published: May 05, 2022
Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria.
Journal: Science translational medicine
Published: January 12, 2022
Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency-associated hypertransaminasemia.
Journal: Hepatology (Baltimore, Md.)
Published: November 15, 2021
Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion.
Journal: Theranostics
Published: September 23, 2021
Primary biliary cholangitis: pathogenic mechanisms.
Journal: Current opinion in gastroenterology
Published: December 17, 2020
Linking the Expression of Therapeutic Genes to Unfolded Protein Response: A New Option for Anti-Hepatitis B Virus Gene Therapy.
Journal: Human gene therapy
Published: November 20, 2020
Identifying Differentially Expressed MicroRNAs, Target Genes, and Key Pathways Deregulated in Patients with Liver Diseases.
Journal: International journal of molecular sciences
Published: August 04, 2020
Brain ventricular enlargement in human and murine acute intermittent porphyria.
Journal: Human molecular genetics
Published: June 19, 2020
Last Updated: 09/26/2026